SUN Yue-li. FDA Approves Atezolizumab in Combination with Chemotherapy for The Initial Treatment of Adults with Extensive-Stage Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2019, 19(2): 65-65. DOI: 10.12019/j.issn.1671-5144.2019.02.001
|
Citation:
|
SUN Yue-li. FDA Approves Atezolizumab in Combination with Chemotherapy for The Initial Treatment of Adults with Extensive-Stage Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2019, 19(2): 65-65. DOI: 10.12019/j.issn.1671-5144.2019.02.001
|
SUN Yue-li. FDA Approves Atezolizumab in Combination with Chemotherapy for The Initial Treatment of Adults with Extensive-Stage Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2019, 19(2): 65-65. DOI: 10.12019/j.issn.1671-5144.2019.02.001
|
Citation:
|
SUN Yue-li. FDA Approves Atezolizumab in Combination with Chemotherapy for The Initial Treatment of Adults with Extensive-Stage Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2019, 19(2): 65-65. DOI: 10.12019/j.issn.1671-5144.2019.02.001
|
DownLoad: